Benefits
DashboardNot registered yet? Get a free account.
Sign UpNot registered yet? Get a free account.
Sign Up
You're about to leave our website and go to an external link. Are you sure?
The company produces, develops, markets, and exports generic formulations and branded products in India and internationally.
Caplin Point Laboratories Limited, is a listed public company incorporated on 16 April, 1990. It is classified as a public limited company and is located in Chennai, Tamil Nadu. It's authorized share capital is INR 17.00 cr and the total paid-up capital is INR 15.20 cr.
Read more
Buy Dashboard using Credits
This action will use 1 of your credits. Are you sure you want to go ahead?
Credits Balance:
0
** All rupee values in INR crores. Based on March 2022 numbers.
9.4%
2.66%
20.26%
22.67%
22.43%
1.6
-2.73
0.98
-0.4
-1.1
Buy Report or Plans
Company dashboard
Five year financials and ratios
Risk analysis
Interactive charts
All financials
All annual returns
MoA and AoA
Latest financials
Latest annual return
MoA and AoA
Five year financials and ratios
Shareholding and group structure
Litigation and more
Everything in financial report
Peers and financials
* GST not included
** Reports & MCA filings will be based on the latest available financials.
India
(14)
| State | Type | Address |
|---|
Locations on Map
Filter (4)
Severe Risk
Moderate Risk
Low Risk
Read more
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Sales | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Gross margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Networth | |||||
| Borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Debt to equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ROE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| WC days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Equity Capital | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Reserves | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Borrowings + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Long term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Short term borrowings | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade payables + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other liabilities + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total liabilities | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| CWIP | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Intangible assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| LT loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other non-current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Current assets + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Inventories | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Trade receivables | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cash and cash equivalents | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| ST loans and advances | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other current assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Sales + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Sales growth % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Expenses + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Cost of goods | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Employee cost | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other costs | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating profit + | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Other income | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Depreciation | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Exceptional items | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit before tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Tax | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Profit - disc. ops | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net profit | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net margin % | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | |
|---|---|---|---|---|---|
| Solvency + | |||||
| Total Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Debt/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Debt/Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Assets/Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Liquidity + | |||||
| Current Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Quick Ratio | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Interest Coverage | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Performance | |||||
| Gross Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Operating Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Net Margin | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return + | |||||
| Return on Equity | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROCE | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Return on Assets | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Pre-tax ROIC | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Efficiency + | |||||
| Days Payable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Inventory | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Days Receivable | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Fixed Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Total Asset Turnover | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital | |||||
| Cash Conversion Cycle | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
| Working Capital Days | GET PRO | GET PRO | GET PRO | GET PRO | GET PRO |
The Catholic Syrian Bank Limited
No. of Loans: 1
Total Amount : 40.0 cr
ICICI Bank Limited
No. of Loans: 1
Total Amount : 10.0 cr
Kotak Mahindra Bank Limited
No. of Loans: 1
Total Amount : 7.6 cr
Indian Overseas Bank
No. of Loans: 1
Total Amount : 0.1 cr
| Designation | Name | DIN/PAN | Tenure |
|---|---|---|---|
| Director | Ranganathan Vijayaraghavan | 00026763 | 0 years |
| Director | Paarthipan Chingelput Chellappan
Shareholder
|
01218784 | 31 years |
| Director | Deenadayalan Singaram
Shareholder
|
01951620 | 2 years |
| Managing Director | Sridhar Ganesan
Shareholder
|
06819026 | 11 years |
| Director | Damodaran Sathyanarayanan | 07650566 | 8 years |
| CFO | Desikachari Muralidharan
Shareholder
|
<HIDDEN> | 9 years |
| Director | Gariyali Chanderkanta | 08711546 | 5 years |
| Director | Ramachandramurthy Nagendran | 08943531 | 2 years |
| CS | Venkatram Ganapathisubramanian | <HIDDEN> | 2 years |
| Name | Status | Paid up Capital | Common Directors | Address |
|---|---|---|---|---|
| SANCO TRANS LIMITED |
Active
|
1.8 Cr | 1 | Tamil Nadu |
| VEEYES CHARITIES FOUNDATION |
Active
|
0.0 | 1 | Tamil Nadu |
| SIMPSON AND COMPANY LIMITED |
Active
|
7.4 Cr | 1 | Tamil Nadu |
| THE UNITED NILGIRI TEA ESTATES COMPANY LIMITED |
Active
|
5.0 Cr | 1 | Tamil Nadu |
| SUNDRAM FASTENERS LIMITED |
Active
|
21.0 Cr | 1 | Tamil Nadu |
| LUCAS INDIAN SERVICE LIMITED |
Active
|
4.0 Cr | 1 | Tamil Nadu |
| INDO-LATIN AMERICAN CHAMBER OF COMMERCE & INDUSTRY |
Active
|
0.0 | 1 | Tamil Nadu |
| ASHVICH PROPERTIES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Tamil Nadu |
| CAPLIN ONE PRIVATE LIMITED |
Strike Off
|
15.0 L | 1 | Tamil Nadu |
| CAPLIN STERILES LIMITED |
Active
|
180.0 Cr | 3 | Tamil Nadu |
| CAPLIN ONE LABS LIMITED |
Active
|
70.0 Cr | 5 | Tamil Nadu |
| CEO TSG IR AND LABOUR COMPLIANCE SERVICES PRIVATE LIMITED |
Active
|
1.0 L | 1 | Tamil Nadu |
| CEO SKILL FOUNDATIONS PRIVATE LIMITED |
Active
|
1.0 L | 1 | Tamil Nadu |
| SRIMAN MADHWA SIDHANTAONNAHINI PERMANENT NIDHI LIMITED |
Active
|
9.3 Cr | 1 | Tamil Nadu |
| Name | State / Country | Incorporation Year | Paidup Capital |
|---|---|---|---|
| Argus Salud Pharma LLP | India | - | - |
| Caplin Point Far East Ltd - Hong Kong | Hong Kong | - | - |
| Caplin Point Laboratories SAS - Colombia | Colombia | - | - |
| Caplin Steriles Limited | India | - | - |
| CAPLIN POINT (S) PTE. LTD-Singapore | Singapore | - | - |
| CAPLIN ONE LABS LIMITED | Tamil Nadu | 2021 | ₹ 70.0 Cr |
| Caplin Point Far East Limited Hong Kong | Hong Kong | - | - |
| Caplin Point Laboratories Colombia SAS - Colombia | Colombia | - | - |
| Caplin Point (S) Pte. Limited Singapore | Singapore | - | - |
The incorporation date of CAPLIN POINT LABORATORIES LIMITED is 16 April, 1990
The authorized share capital of CAPLIN POINT LABORATORIES LIMITED is INR ₹ 17.0 Cr.
The paid-up capital of CAPLIN POINT LABORATORIES LIMITED is INR ₹ 15.2 Cr.
The registered address of CAPLIN POINT LABORATORIES LIMITED is Ashvich Towers, 3rd Floor, No.3, Developed Plots, Indust rial Estates,Per ungudi NA Chennai Chennai Tamil Nadu - 600096
The CIN number of CAPLIN POINT LABORATORIES LIMITED is L24231TN1990PLC019053.
Expand
Delete
Collapse
See
details
It will take sometime. Please come back in 10
minutes
